Categories: Wire Stories

Universal Display Corporation Sponsors and Presents at ICDT 2023

EWING, N.J.–(BUSINESS WIRE)–$OLED #OLEDUniversal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED technology and materials, today announced its sponsorship and presentation at the International Conference on Display Technology (ICDT) 2023 (2023????????). Hosted by the Society for Information Display (SID), ICDT 2023 will be held March 31-April 3 at Nanjing International Exhibition Center, China.

“We are pleased to share our cutting-edge research work at the upcoming ICDT 2023 and to continue our sponsorship of this global display symposium and exhibition in China,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation. “The proliferation of OLEDs continues to broaden in the consumer electronics landscape, from AR/VR and smartwatches, to smartphones, IT, automotive and TV applications. As a key enabler in the OLED ecosystem, UDC is continuing to invent and develop next-generation phosphorescent materials and technologies to enable higher energy efficiency and performance for our customers and for consumers around the world.”

This year’s ICDT Symposium will include presentations by Universal Display’s team discussing UDC’s energy-efficiency roadmap, including our current and next-generation PHOLED technology and materials as well as our groundbreaking Plasmonic PHOLED platform for the next frontier of energy efficiency and lifetime gains. In addition, senior representatives from UDC Beijing, Chengdu, Hong Kong, Shanghai and Shenzhen subsidiaries will attend the conference in Nanjing.

  • Session 18: OLED Devices 2 (OLEDs), where Dr. Nicholas Thompson, Associate Director, PHOLED R&D, of Universal Display will virtually present his Invited Paper on “Efficiency, Stability, and Angular Dependence of Plasmonic PHOLEDs,” on Sunday, April 2nd at 3:20 PM CST.
  • Session 32: OLED Displays (OLEDs), where Dr. Mike Weaver, Vice President, PHOLED R&D, of Universal Display will virtually present his Invited Paper on “Future OLED Displays,” on Monday, April 3rd at 8:30 AM CST.

About Universal Display Corporation

Universal Display Corporation (Nasdaq: OLED) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. Founded in 1994 and with subsidiaries and offices around the world, the Company currently owns, exclusively licenses or has the sole right to sublicense more than 5,500 patents issued and pending worldwide. Universal Display licenses its proprietary technologies, including its breakthrough high-efficiency UniversalPHOLED® phosphorescent OLED technology that can enable the development of energy-efficient and eco-friendly displays and solid-state lighting. The Company also develops and offers high-quality, state-of-the-art UniversalPHOLED materials that are recognized as key ingredients in the fabrication of OLEDs with peak performance. In addition, Universal Display delivers innovative and customized solutions to its clients and partners through technology transfer, collaborative technology development and on-site training. To learn more about Universal Display Corporation, please visit https://oled.com/.

Universal Display Corporation and the Universal Display Corporation logo are trademarks or registered trademarks of Universal Display Corporation. All other company, brand or product names may be trademarks or registered trademarks.

All statements in this document that are not historical, such as those relating to the projected adoption, development and advancement of the Company’s technologies, and the Company’s expected results and future declaration of dividends, as well as the growth of the OLED market and the Company’s opportunities in that market, are forward-looking financial statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this document, as they reflect Universal Display Corporation’s current views with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated. These risks and uncertainties are discussed in greater detail in Universal Display Corporation’s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, including, in particular, the section entitled “Risk Factors” in Universal Display Corporation’s Annual Report on Form 10-K for the year ended December 31, 2022. Universal Display Corporation disclaims any obligation to update any forward-looking statement contained in this document.

Follow Universal Display Corporation

Twitter
Facebook
YouTube

(OLED-C) 

Contacts

Universal Display Contact:
Darice Liu

investor@oled.com
media@oled.com
+1 609-964-5123

Alex

Recent Posts

Hong Kong Design Centre Welcomes ‘Blueprint for Arts and Culture and Creative Industries Development’

HONG KONG SAR - Media OutReach Newswire - 27 November 2024 - Hong Kong Design…

12 minutes ago

Preserving the beauty of nature – a bond that links Lancang-Mekong countries

CHENGDU CITY, CHINA - Media OutReach Newswire - 27 November 2024 - Taking its source…

12 minutes ago

Arirang TV presents Korea’s one-day trip entertainment show “¡Hola, Corea!” for South American viewers

- Arirang TV's one-day trip entertainment “¡Hola, Corea!”, specially produced for South American viewers, will…

2 hours ago

Gartner Announces the Gartner CFO & Finance Executive Conference 2025 in Sydney

--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT): What:   Gartner CFO and Finance Executive Conference 2025  …

2 hours ago

Northern Trust Asset Management 2025 Global Investment Outlook: Expect U.S. Stocks to Outperform; High Yield Bond Market Is Attractive

Earnings Growth Backs U.S. Equities; Strong Credit Quality Supports High Yield Market; U.S. Money Market…

2 hours ago

S.BIOMEDICS Investigational Cell Therapy for Parkinson’s Disease With TED-A9 Shows Positive Data at 12-months in Phase 1/2a Clinical Trial

TED-A9 is high-purity ventral midbrain dopaminergic progenitor cells derived from human embryonic stem cells (hESCs)…

2 hours ago